Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Structural and antigenic variations in the spike protein of emerging SARS-CoV-2 variants.

PLoS pathogens - 1 Feb 2022

Mittal Anshumali, Khattri Arun, Verma Vikash

Abstract excerpt

The Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) virus is continuously evolving, and this poses a major threat to antibody therapies and currently authorized Coronavirus Disease 2019 (COVID-19) vaccines. It is therefore of utmost importance to investigate and predict the putative mutations on the spike protein that confer immune evasion. Antibodies are key components of the human immune system's...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antibodies, Neutralizing
Share to Antibodies, Viral
Share to Antigenic Variation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to COVID-19 Vaccines

Share to Epitopes

Share to Immune Evasion

Share to Models, Structural

Share to Spike Glycoprotein, Coronavirus

Source

Open in PubMed Open full text

Identifiers

PMID: 35176090
DOI: 10.1371/journal.ppat.1010260
PMCID: PMC8853550

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Structural and antigenic variations in the spike protein of emerging SARS-CoV-2 variants.PMID 35176090Read ↗

Structural Insights into the SARS-CoV-2 Spike Protein and Its Implications for Antibody Resistance.Semantic proximity Read ↗

SARS-CoV-2 variants, spike mutations and immune escape.Semantic proximity Read ↗

Neutralising antibody escape of SARS-CoV-2 spike protein: Risk assessment for antibody-based Covid-19 therapeutics and vaccines.Semantic proximity Read ↗

SARS-CoV-2 variants of concern: spike protein mutational analysis and epitope for broad neutralizationSemantic proximity Read ↗

What makes SARS‐CoV‐2 unique? Focusing on the spike proteinSemantic proximity Read ↗

Mutations of SARS-CoV-2 spike protein: Implications on immune evasion and vaccine-induced immunity.Semantic proximity Read ↗

Insertion in the N-Terminal Domain of the SARS-CoV-2 Spike Glycoprotein Affects Antibody Recognition and Phenotypic Properties.Semantic proximity Read ↗

The SARS-CoV-2 neutralizing antibody response to SD1 and its evasion by BA.2.86Semantic proximity Read ↗

Neutralization potency of monoclonal antibodies recognizing dominant and subdominant epitopes on SARS-CoV-2 Spike is impacted by the B.1.1.7 variant.Semantic proximity Read ↗

The great escape? SARS-CoV-2 variants evading neutralizing responses.Semantic proximity Read ↗

Immune Evasion of SARS-CoV-2 Emerging Variants: What Have We Learnt So Far?Semantic proximity Read ↗

Defining variant-resistant epitopes targeted by SARS-CoV-2 antibodies: A global consortium studySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.